Medial epicondylitis, often known as golfer’s elbow, is a long-term overuse injury that impacts the tendons attaching the flexor-pronator muscle group to the medial epicondyle, a bony bump on the inside of the elbow. It causes pain, tenderness, and limited mobility, which, in moderate to severe cases, can significantly disrupt work and daily routines.
The condition parallels lateral epicondylitis (tennis elbow) in its fundamental pathology. Still, it involves the opposite tendon group and manifests as pain on the medial rather than the lateral aspect of the elbow. Although it is less common than its lateral counterpart, medial epicondylitis is by no means infrequent and impacts a wide demographic of individuals engaged in forceful or repetitive forearm movements.
The flexor-pronator tendon complex, attached at the medial epicondyle, bears load during wrist flexion, forearm pronation, and gripping. Repeated or intense use can exceed its healing ability, leading to accumulated microtrauma.
During the acute and subacute phases, inflammatory mediators are found at the tendon surface. In chronic cases, histological studies typically show tendinosis rather than tendinitis, characterized by disorganized collagen, increased ground substance, and ingrowths of immature blood vessels into degenerated tendon areas. This structural remodeling weakens tensile strength and accounts for the recurring pain often triggered by minor provocation.
Contributing risk factors include:
Pain and point tenderness along the inner elbow—particularly over or just distal to the medial epicondyle—are the defining features. The discomfort is characteristically reproduced by resisted wrist flexion and forearm pronation on examination.
Additional findings commonly reported include:
Symptom severity frequently varies, often intensifying during periods of heightened activity and partially alleviating with rest. Such variability can result in delayed presentation, as patients may attribute their discomfort to temporary overexertion rather than to an underlying progressive structural condition.
Medial epicondylitis occurs less frequently than lateral epicondylitis and has a lower annual prevalence in the general adult population. It is observed in both athletic and non-athletic groups, with occupational exposure serving as the primary contributing factor in most clinical cohorts.
Golfers constitute only a minor proportion of the cases, despite the condition’s common designation. The majority of affected individuals are in their forties or fifties, a period when accumulated tendon stress coincides with age-related declines in collagen synthesis and reparative capacity.
Diagnosis is established through clinical examination, with imaging used when indicated. The physician assesses tenderness over the medial epicondyle, evaluates active and passive elbow range of motion, and performs resisted wrist flexion and valgus stress testing to characterize the condition and rule out ligamentous involvement.
Diagnostic ultrasound is a valuable first-line imaging tool. It enables real-time visualization of:
When ulnar nerve involvement is suspected, sonographic assessment of the nerve’s path through the cubital tunnel can be performed. MRI is typically reserved for complex cases, those with diagnostic uncertainty (such as suspected deep ligament issues), or for surgical planning.
Treatment choice depends on symptom duration, imaging findings of structural damage, and the functional needs of the affected arm. Typically, a staged approach is used, starting with conservative treatments and moving to regenerative therapies as needed.
Initial management typically includes:
When tendon degeneration is confirmed or symptoms last for several months, advanced non-surgical options can be considered. Extracorporeal Shockwave Therapy (ESWT) uses focused acoustic energy to treat degenerative tissue, promoting collagen remodeling and enhancing blood flow to the area. Platelet-Rich Plasma (PRP) therapy involves concentrating the patient’s own platelets and injecting them directly into the affected tendon under ultrasound guidance, delivering high levels of growth factors to aid in tissue repair.
Low-Level Light Therapy (LLLT) can be used as a non-invasive supplement to target cellular energy and inflammatory signals in soft tissues. For more severe cases with notable degeneration or partial tears, biologic treatments such as MSC-derived exosome therapy may be considered after a thorough medical assessment.
Surgical intervention is rarely necessary, typically only after a prolonged period of conservative and regenerative treatments has not yielded significant clinical improvement.
Not all patients with medial elbow pain need regenerative or procedural treatments. The most important first step is an accurate diagnosis—differentiating tendon degeneration from ulnar collateral ligament injury, nerve entrapment, or intra-articular joint issues, as each condition has a unique clinical course and requires different treatments.
Delayed diagnosis can lead to ongoing tissue degeneration, the development of compensatory movement patterns around chronic pain, and longer, more complicated recoveries. Conducting a comprehensive evaluation early in the symptom course helps maintain tissue health and simplifies treatment options.